Gemfibrozil

Back to search

Molecule Structure

Scientific Name

Gemfibrozil

Description of the Drug

Gemfibrozil is a lipid regulator that is used in the reduction of serum triglyceride levels in high-risk patients with hyperlipidemia.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01241

Brand Name(s)

Emfib, Gemfibrozil, Lopid

Company Owner(s)

Cadila Healthcare Ltd, Apotex Inc, Teva Pharmaceuticals Usa Inc, Impax Pharmaceuticals, Sun Pharmaceutical Industries Inc, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Northstar Healthcare Holdings Ltd, Ascent Pharmaceuticals Inc, Chartwell Rx Sciences Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Peroxisome proliferator-activated receptor alpha SINGLE PROTEIN AGONIST CHEMBL239

Unichem Links

Atlas gemfibrozil
SureChEMBL SCHEMBL4813
PharmGKB PA449750
Human Metabolome Database HMDB0015371
DrugBank DB01241
PubChem: Thomson Pharma 14798621
PubChem 3463
Mcule MCULE-4563546953
LINCS LSM-2227
Nikkaji J40.721F
PDBe 4TX
BindingDB 50110590
EPA CompTox Dashboard DTXSID0020652
DrugCentral 1285
Brenda 6087
ChemicalBook CB9154247
Guide to Pharmacology 3439
rxnorm LOPID GEMFIBROZIL
PubChem: Drugs of the Future 12013353
KEGG Ligand C07020
ChEBI 5296
ZINC ZINC000001530641